CohBar to Present at the Oppenheimer Fall Healthcare, Life Sciences, & MedTech Summit

MENLO PARK, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will present a company update at the Oppenheimer Fall Healthcare, Life Sciences, & MedTech Summit, being held virtually on September 21-23, 2020.

Click to view original post